FDA Breakthrough Therapy Nod for Zoldonrasib Marks Major Milestone for Revolution Medicines
Market Chameleon (Fri, 9-Jan 10:35 AM)
FDA Grants Breakthrough Therapy Status to Revolution Medicines’ Zoldonrasib for Rare KRAS G12D Lung Cancer
Market Chameleon (Thu, 8-Jan 8:14 AM)
